New Delhi: The Drug Controller General of India (DCGI) on Wednesday approved the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine developed by Serum Institute of India, Pune.
The vaccine will be used to create active immunization against invasive disease and pneumonia caused by ‘Streptococcus pneumonia’ among infants. It is administered in an intramuscular manner.
Three phases of clinical trials were conducted in India as well as in Africa’s Gambia.
The institute has been granted permission to manufacture the Pneumococcal Polysaccharide Conjugate Vaccine domestically. This is the first indigenously developed vaccine in the field of pneumonia.
Earlier, this vaccine had to be imported.
Also Read:- Corona Vaccine Update: UK’s Imperial College To Begin Phase 1 Human Trials On June 15
Stay ahead with Odisha Bytes Breaking News - your ultimate source for the fastest, most… Read More
Mumbai: Fans go crazy and sometimes cross all limits when they come across celebrities. There… Read More
Bhubaneswar: Four Odia workers from Ganjam district, who were stranded in Oman, have safely returned… Read More
Mumbai: Actress Shehnaaz Gill is enjoying her vacation in Sydney, as is evident from the… Read More
Mumbai: Actress Rakhi Sawant, known for her bold and controversial comments, was recently summoned by… Read More
Bhubaneswar: In the FIH Pro League 2024-25 matches on 21 February, Friday, India faced off… Read More
This website uses cookies.
